Gülberk Uçar

A new therapeutic approach in Alzheimer disease: Some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics

Nesrin Gökhan-Kelekçi, Samiye Yabanoğlu, Esra Küpeli̇ et al. · Bioorganic & Medicinal Chemistry · 2007 · 228 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity

Nesrin Gökhan-Kelekçi, Semra Koyunoğlu, Samiye Yabanoğlu et al. · Bioorganic & Medicinal Chemistry · 2008 · 157 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The Effect of Exopolysaccharide-Producing Probiotic Strains on Gut Oxidative Damage in Experimental Colitis

Neriman Şengül, Sevil Işık, Belma Aslım et al. · Digestive Diseases and Sciences · 2010 · 118 citations

Life Sciences, Immunology, Microbiology +16

Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro

İpek Baysal, Gülberk Uçar, Merve Gültekinoğlu et al. · Journal of Neural Transmission · 2016 · 117 citations

Pharmacy, Pharmaceutics, Pharmacology +16

1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: A novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases

Gülberk Uçar, Nesrın Gökhan, Akgül Yeşilada et al. · Neuroscience Letters · 2005 · 91 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16